Skip to main content
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1987 Jan 24;294(6566):211–213. doi: 10.1136/bmj.294.6566.211

Prognosis of children who are carriers of hepatitis B.

S M Wheeley, E H Boxall, M J Tarlow
PMCID: PMC1245227  PMID: 3101814

Abstract

Fifteen children who had become positive for hepatitis B surface antigen (HBsAg) by perinatal transmission were traced and re-examined after a mean of 8.1 years; all had been born in England to mothers from ethnic minorities who were carriers of HBsAg. Fourteen of the children remained carriers of HBsAg; of these, more girls than boys developed antibody to hepatitis B e antigen (anti-HBe). Those children whose transaminase activities had been above normal within the first three years of life were more likely to have developed anti-HBe. The earlier production of anti-HBe suggests that girls have a more effective immune response. Increased transaminase activity early in the course of asymptomatic carriage of HBsAg may be a favourable prognostic sign.

Full text

PDF
211

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arthur M. J., Hall A. J., Wright R. Hepatitis B, hepatocellular carcinoma, and strategies for prevention. Lancet. 1984 Mar 17;1(8377):607–610. doi: 10.1016/s0140-6736(84)91006-7. [DOI] [PubMed] [Google Scholar]
  2. Beasley R. P., Hwang L. Y., Lin C. C., Leu M. L., Stevens C. E., Szmuness W., Chen K. P. Incidence of hepatitis B virus infections in preschool children in Taiwan. J Infect Dis. 1982 Aug;146(2):198–204. doi: 10.1093/infdis/146.2.198. [DOI] [PubMed] [Google Scholar]
  3. Beasley R. P., Shiao I. S., Wu T. C., Hwang L. Y. Hepatoma in an HBsAg carrier--seven years after perinatal infection. J Pediatr. 1982 Jul;101(1):83–84. doi: 10.1016/s0022-3476(82)80190-x. [DOI] [PubMed] [Google Scholar]
  4. Blumberg B. S. Sex differences in response to hepatitis B virus. I. History. Arthritis Rheum. 1979 Nov;22(11):1261–1266. doi: 10.1002/art.1780221114. [DOI] [PubMed] [Google Scholar]
  5. Blumberg B. S., Sutnick A. I., London W. T., Melartin L. Sex distribution of Australia antigen. Arch Intern Med. 1972 Aug;130(2):227–231. [PubMed] [Google Scholar]
  6. Derso A., Boxall E. H., Tarlow M. J., Flewett T. H. Transmission of HBsAg from mother to infant in four ethnic groups. Br Med J. 1978 Apr 15;1(6118):949–952. doi: 10.1136/bmj.1.6118.949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Glezen P., Denny F. W. Epidemiology of acute lower respiratory disease in children. N Engl J Med. 1973 Mar 8;288(10):498–505. doi: 10.1056/NEJM197303082881005. [DOI] [PubMed] [Google Scholar]
  8. Hall A. J., Winter P. D., Wright R. Mortality of hepatitis B positive blood donors in England and Wales. Lancet. 1985 Jan 12;1(8420):91–93. doi: 10.1016/s0140-6736(85)91976-2. [DOI] [PubMed] [Google Scholar]
  9. Karayiannis P., Fowler M. J., Lok A. S., Greenfield C., Monjardino J., Thomas H. C. Detection of serum HBV-DNA by molecular hybridisation. Correlation with HBeAg/anti-HBe status, racial origin, liver histology and hepatocellular carcinoma. J Hepatol. 1985;1(2):99–106. doi: 10.1016/s0168-8278(85)80759-5. [DOI] [PubMed] [Google Scholar]
  10. Lutwick L. I. Relation between aflatoxin, hepatitis-B virus, and hepatocellular carcinoma. Lancet. 1979 Apr 7;1(8119):755–757. doi: 10.1016/s0140-6736(79)91210-8. [DOI] [PubMed] [Google Scholar]
  11. Realdi G., Alberti A., Rugge M., Bortolotti F., Rigoli A. M., Tremolada F., Ruol A. Seroconversion from hepatitis B e antigen to anti-HBe in chronic hepatitis B virus infection. Gastroenterology. 1980 Aug;79(2):195–199. [PubMed] [Google Scholar]
  12. Said S., Larouze B., Biaud J. M., Sabbagh K., Yang C., Gaumer B., Jemmali M., Gaudebout C. Seroepidemiology of hepatitis B in a population of children in central Tunisia. Int J Epidemiol. 1985 Jun;14(2):313–317. doi: 10.1093/ije/14.2.313. [DOI] [PubMed] [Google Scholar]
  13. Skinhøj P. Infection with hepatitis B virus in infancy. A longitudinal study of 8 cases. Arch Dis Child. 1978 Sep;53(9):746–748. doi: 10.1136/adc.53.9.746. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Supran E. M., Boxall E. H., Craske J., Hart R. J., Vandervelde E. M., Gardner P. S. Enzyme-linked immunosorbent assay (ELISA) for the detection of hepatitis Be antigen and antibody: report of a field trial. J Clin Pathol. 1983 May;36(5):581–585. doi: 10.1136/jcp.36.5.581. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Szmuness W. Hepatocellular carcinoma and the hepatitis B virus: evidence for a causal association. Prog Med Virol. 1978;24:40–69. [PubMed] [Google Scholar]
  16. Viola L. A., Barrison I. G., Coleman J. C., Paradinas F. J., Murray-Lyon I. M. The HBe antigen-antibody system and its relationship to clinical and laboratory findings in 100 chronic HBsAg carriers in Great Britain. J Med Virol. 1981;8(3):169–175. doi: 10.1002/jmv.1890080303. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES